These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Norepinephrine and MHPG levels in CSF and plasma in Alzheimer's disease. Raskind MA, Peskind ER, Halter JB, Jimerson DC. Arch Gen Psychiatry; 1984 Apr 06; 41(4):343-6. PubMed ID: 6703854 [Abstract] [Full Text] [Related]
5. Noradrenergic response to intravenous yohimbine in patients with depression and comorbidity of depression and panic. Guthrie SK, Grunhaus L, Pande AC, Hariharan M. Biol Psychiatry; 1993 Oct 15; 34(8):558-61. PubMed ID: 8274583 [Abstract] [Full Text] [Related]
6. Noradrenergic function and the mechanism of action of antianxiety treatment. II. The effect of long-term imipramine treatment. Charney DS, Heninger GR. Arch Gen Psychiatry; 1985 May 15; 42(5):473-81. PubMed ID: 2985014 [Abstract] [Full Text] [Related]
7. Clinical improvement with fluoxetine therapy and noradrenergic function in patients with panic disorder. Coplan JD, Papp LA, Pine D, Martinez J, Cooper T, Rosenblum LA, Klein DF, Gorman JM. Arch Gen Psychiatry; 1997 Jul 15; 54(7):643-8. PubMed ID: 9236548 [Abstract] [Full Text] [Related]
8. Noradrenergic function in generalized anxiety disorder, major depressive disorder, and healthy subjects. Sevy S, Papadimitriou GN, Surmont DW, Goldman S, Mendlewicz J. Biol Psychiatry; 1989 Jan 15; 25(2):141-52. PubMed ID: 2539200 [Abstract] [Full Text] [Related]
11. Noradrenergic function and hypothalamic-pituitary-adrenal axis activity in primary unipolar major depressive disorder. de Villiers AS, Russell VA, Carstens ME, Aalbers C, Gagiano CA, Chalton DO, Taljaard JJ. Psychiatry Res; 1987 Oct 15; 22(2):127-40. PubMed ID: 3120204 [Abstract] [Full Text] [Related]
16. Plasma MHPG response to yohimbine treatment in women with hypoactive sexual desire. Piletz JE, Segraves KB, Feng YZ, Maguire E, Dunger B, Halaris A. J Sex Marital Ther; 1998 Oct 15; 24(1):43-54. PubMed ID: 9509380 [Abstract] [Full Text] [Related]
17. Plasma 3,4-dihydroxyphenylglycol (DHPG) and 3-methoxy-4-hydroxyphenylglycol (MHPG) are insensitive indicators of alpha 2-adrenoceptor mediated regulation of norepinephrine release in healthy human volunteers. Scheinin M, Karhuvaara S, Ojala-Karlsson P, Kallio A, Koulu M. Life Sci; 1991 Oct 15; 49(1):75-84. PubMed ID: 1646924 [Abstract] [Full Text] [Related]
18. The effect of desmethylimipramine on the metabolism of norepinephrine. Zavadil AP, Ross RJ, Calil HM, Linnoila M, Blombery P, Jimerson DC, Kopin IJ, Potter WZ. Life Sci; 1984 Sep 03; 35(10):1061-8. PubMed ID: 6482645 [Abstract] [Full Text] [Related]
19. Sulfate and glucuronide conjugates of 3-methoxy-4-hydroxyphenylglycol (MHPG) in urine of depressed patients: central and peripheral influences. Peyrin L, Pequignot JM, Chauplannaz G, Laurent B, Aimard G. J Neural Transm; 1985 Sep 03; 63(3-4):255-69. PubMed ID: 4067598 [Abstract] [Full Text] [Related]
20. Relationship between plasma and cerebrospinal fluid norepinephrine and dopamine metabolites in a nonhuman primate. Greene KA, Faull KF. J Neurochem; 1989 Oct 03; 53(4):1007-13. PubMed ID: 2769251 [Abstract] [Full Text] [Related] Page: [Next] [New Search]